FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer

Cancer Letters

Volumn 340, Issue 1, 2013, Pages 104-112

  Yang, Chao ^a   Chen, Hui ^a   Tan, Guixiang ^a   Gao, Wei ^a   Cheng, Liang ^a   Jiang, Xia ^a   Yu, Li ^a   Tan, Yongjun ^a  

^a HUNAN UNIVERSITY   (China)

Author keywords

Breast cancer; EMT; FOXM1 transcription factor; Slug Transcription

Indexed keywords

FORKHEAD BOX M1; FORKHEAD TRANSCRIPTION FACTOR; MESSENGER RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CONTROLLED STUDY; E CADHERIN GENE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FORKHEAD BOX M1 GENE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE CANCER; INTESTINE METASTASIS; LUNG METASTASIS; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SLUG GENE; SNAIL GENE; TRANSCRIPTION INITIATION; TUMOR PROMOTION; TWIST GENE; UPREGULATION; VIMENTIN GENE;

BREAST CANCER; EMT; FOXM1 TRANSCRIPTION FACTOR; SLUG TRANSCRIPTION;

ANIMALS; BREAST NEOPLASMS; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL NEOPLASMS; LUNG NEOPLASMS; MCF-7 CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASTIC CELLS, CIRCULATING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84883763813     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.07.004     Document Type: Article

References (72)

1. Lim J., Thiery J.P. Epithelial-mesenchymal transitions: insights from development. Development 2012, 139:3471-3486.
2. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
3. Arnoux V., Nassour M., L'Helgoualc'h A., Hipskind R.A., Savagner P. Erk5 controls Slug expression and keratinocyte activation during wound healing. Mol. Biol. Cell 2008, 19:4738-4749.
4. Ikegami T., Zhang Y., Matsuzaki Y. Liver fibrosis: possible involvement of EMT. Cells Tissues Organs 2007, 185:213-221.
5. Carew R.M., Wang B., Kantharidis P. The role of EMT in renal fibrosis. Cell Tissue Res. 2012, 347:103-116.
6. Tiwari N., Gheldof A., Tatari M., Christofori G. EMT as the ultimate survival mechanism of cancer cells. Semin. Cancer Biol. 2012, 22:194-207.
7. P. Savagner, The epithelial-mesenchymal transition (EMT) phenomenon. Ann. Oncol. 21 Suppl. 7 (2010) vii89-92.
8. Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 2009, 9:265-273.
9. Xue C., Plieth D., Venkov C., Xu C., Neilson E.G. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res. 2003, 63:3386-3394.
10. M.H. Forouzanfar, K.J. Foreman, A.M. Delossantos, R. Lozano, A.D. Lopez, C.J. Murray, M. Naghavi, Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis, Lancet 378 (2011) 1461-1484.
11. Robson E.J., Khaled W.T., Abell K., Watson C.J. Epithelial-to-mesenchymal transition confers resistance to apoptosis in three murine mammary epithelial cell lines. Differentiation 2006, 74:254-264.
12. Derksen P.W., Liu X., Saridin F., van der Gulden H., Zevenhoven J., Evers B., van Beijnum J.R., Griffioen A.W., Vink J., Krimpenfort P., Peterse J.L., Cardiff R.D., Berns A., Jonkers J. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 2006, 10:437-449.
13. Mittal M.K., Singh K., Misra S., Chaudhuri G. SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination. J. Biol. Chem. 2011, 286:469-479.
14. Morel A.P., Lievre M., Thomas C., Hinkal G., Ansieau S., Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 2008, 3:e2888.
15. Vesuna F., Lisok A., Kimble B., Raman V. Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Neoplasia 2009, 11:1318-1328.
16. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100:3983-3988.
17. Brabletz T., Jung A., Spaderna S., Hlubek F., Kirchner T. Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat. Rev. Cancer 2005, 5:744-749.
18. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K., Brisken C., Yang J., Weinberg R.A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
19. Lo H.W., Hsu S.C., Xia W., Cao X., Shih J.Y., Wei Y., Abbruzzese J.L., Hortobagyi G.N., Hung M.C. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res. 2007, 67:9066-9076.
20. Hardy K.M., Booth B.W., Hendrix M.J., Salomon D.S., Strizzi L. ErbB/EGF signaling and EMT in mammary development and breast cancer. J. Mammary Gland Biol. Neoplasia 2010, 15:191-199.
21. Wendt M.K., Smith J.A., Schiemann W.P. Transforming growth factor-beta-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Oncogene 2010, 29:6485-6498.
22. Asiedu M.K., Ingle J.N., Behrens M.D., Radisky D.C., Knutson K.L. TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype. Cancer Res. 2011, 71:4707-4719.
23. de Graauw M., van Miltenburg M.H., Schmidt M.K., Pont C., Lalai R., Kartopawiro J., Pardali E., Le Devedec S.E., Smit V.T., van der Wal A., Van't Veer L.J., Cleton-Jansen A.M., ten Dijke P., van de Water B. Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc. Natl. Acad. Sci. USA 2010, 107:6340-6345.
24. Wei W., Liu W., Cassol C.A., Zheng W., Asa S.L., Ezzat S. The breast cancer susceptibility gene product fibroblast growth factor receptor 2 serves as a scaffold for regulation of NF-kappaB signaling. Mol. Cell. Biol. 2012, 32:4662-4673.
25. Twigg S.R., Wilkie A.O. Characterisation of the human snail (SNAI1) gene and exclusion as a major disease gene in craniosynostosis. Hum. Genet. 1999, 105:320-326.
26. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., Portillo F., Nieto M.A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2000, 2:76-83.
27. Cohen M.E., Yin M., Paznekas W.A., Schertzer M., Wood S., Jabs E.W. Human SLUG gene organization, expression, and chromosome map location on 8q. Genomics 1998, 51:468-471.
28. Alves C.C., Carneiro F., Hoefler H., Becker K.F. Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. Front Biosci. 2009, 14:3035-3050.
29. Bourgeois P., Stoetzel C., Bolcato-Bellemin A.L., Mattei M.G., Perrin-Schmitt F. The human H-twist gene is located at 7p21 and encodes a B-HLH protein that is 96% similar to its murine M-twist counterpart. Mamm. Genome 1996, 7:915-917.
30. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., Savagner P., Gitelman I., Richardson A., Weinberg R.A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939.
31. Kaestner K.H., Knochel W., Martinez D.E. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev. 2000, 14:142-146.
32. Costa R.H., Kalinichenko V.V., Holterman A.X., Wang X. Transcription factors in liver development, differentiation, and regeneration. Hepatology 2003, 38:1331-1347.
33. Ye H., Kelly T.F., Samadani U., Lim L., Rubio S., Overdier D.G., Roebuck K.A., Costa R.H. Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues. Mol. Cell. Biol. 1997, 17:1626-1641.
34. Wang X., Quail E., Hung N.-J., Tan Y., Ye H., Costa R.H. Increased levels of forkhead Box M1B transcription factor in transgenic mouse hepatocytes prevents age-related proliferation defects in regenerating liver. Proc. Natl. Acad. Sci. USA 2001, 98:11468-11473.
35. Laoukili J., Kooistra M.R., Bras A., Kauw J., Kerkhoven R.M., Morrison A., Clevers H., Medema R.H. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat. Cell Biol. 2005, 7:126-136.
36. Wang I.C., Chen Y.J., Hughes D., Petrovic V., Major M.L., Park H.J., Tan Y., Ackerson T., Costa R.H. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol. Cell. Biol. 2005, 25:10875-10894.
37. Zhang Y., Zhang N., Dai B., Liu M., Sawaya R., Xie K., Huang S. FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells. Cancer Res. 2008, 68:8733-8742.
38. Li Q., Zhang N., Jia Z., Le X., Dai B., Wei D., Huang S., Tan D., Xie K. Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. Cancer Res. 2009, 69:3501-3509.
39. Tan Y., Raychaudhuri P., Costa R.H. Chk2 mediates stabilization of the FoxM1 Transcription factor to stimulate expression of DNA repair genes mol. Cell. Biol. 2007, 27:1007-1016.
40. Li S.K.M., Smith D.K., Leung W.Y., Cheung A.M.S., Lam E.W.F., Dimri G.P., Yao K.-M. FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression. J. Biol. Chem. 2008, 283:16545-16553.
41. Tan Y., Chen Y., Yu L., Zhu H., Meng X., Huang X., Meng L., Ding M., Wang Z., Shan L. Two-fold elevation of expression of FoxM1 transcription factor in mouse embryonic fibroblasts enhances cell cycle checkpoint activity by stimulating p21 and Chk1 transcription. Cell Prolif. 2010, 43:494-504.
42. Xie Z., Tan G., Ding M., Dong D., Chen T., Meng X., Huang X., Tan Y. Foxm1 transcription factor is required for maintenance of pluripotency of P19 embryonal carcinoma cells. Nucleic Acids Res. 2010, 38:8027-8038.
43. Bektas N., Haaf A., Veeck J., Wild P.J., Luscher-Firzlaff J., Hartmann A., Knuchel R., Dahl E. Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer. BMC Cancer 2008, 8:42.
44. Curtis C., Shah S.P., Chin S.F., Turashvili G., Rueda O.M., Dunning M.J., Speed D., Lynch A.G., Samarajiwa S., Yuan Y., Graf S., Ha G., Haffari G., Bashashati A., Russell R., McKinney S., Langerod A., Green A., Provenzano E., Wishart G., Pinder S., Watson P., Markowetz F., Murphy L., Ellis I., Purushotham A., Borresen-Dale A.L., Brenton J.D., Tavare S., Caldas C., Aparicio S. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012, 486:346-352.
45. Wang Z., Ahmad A., Li Y., Banerjee S., Kong D., Sarkar F.H. Forkhead box M1 transcription factor: a novel target for cancer therapy. Cancer Treat. Rev. 2010, 36:151-156.
46. Chen H., Yang C., Yu L., Xie L., Hu J., Zeng L., Tan Y. Adenovirus-mediated RNA interference targeting FOXM1 transcription factor suppresses cell proliferation and tumor growth of nasopharyngeal carcinoma. J. Gene. Med. 2012, 14:231-240.
47. Yang C., Chen H., Yu L., Shan L., Xie L., Hu J., Chen T., Tan Y. Inhibition of FOXM1 transcription factor suppresses cell proliferation and tumor growth of breast cancer. Cancer Gene Ther. 2013, 20:117-124.
48. Wang Z., Banerjee S., Kong D., Li Y., Sarkar F.H. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res. 2007, 67:8293-8300.
49. Lynch T.P., Ferrer C.M., Jackson S.R., Shahriari K.S., Vosseller K., Reginato M.J. Critical role of O-linked beta-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. J. Biol. Chem. 2012, 287:11070-11081.
50. Xue Y.J., Xiao R.H., Long D.Z., Zou X.F., Wang X.N., Zhang G.X., Yuan Y.H., Wu G.Q., Yang J., Wu Y.T., Xu H., Liu F.L., Liu M. Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma. J. Transl. Med. 2012, 10:200.
51. Balli D., Ustiyan V., Zhang Y., Wang I.C., Masino A.J., Ren X., Whitsett J.A., Kalinichenko V.V., Kalin T.V. Foxm1 transcription factor is required for lung fibrosis and epithelial-to-mesenchymal transition. EMBO J. 2013, 32:231-244.
52. Kretschmer C., Sterner-Kock A., Siedentopf F., Schoenegg W., Schlag P.M., Kemmner W. Identification of early molecular markers for breast cancer. Mol. Cancer 2011, 10:15.
53. Yau C., Wang Y., Zhang Y., Foekens J.A., Benz C.C. Young age, increased tumor proliferation and FOXM1 expression predict early metastatic relapse only for endocrine-dependent breast cancers. Breast Cancer Res. Treat. 2011, 126:803-810.
54. Ahmad A., Wang Z., Kong D., Ali S., Li Y., Banerjee S., Ali R., Sarkar F.H. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Breast Cancer Res. Treat. 2010, 122:337-346.
55. Liao J., Cui C., Chen S., Ren J., Chen J., Gao Y., Li H., Jia N., Cheng L., Xiao H., Xiao L. Generation of induced pluripotent stem cell lines from adult rat cells. Cell Stem Cell 2009, 4:11-15.
56. Vleminckx K., Vakaet L., Mareel M., Fiers W., van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991, 66:107-119.
57. Hajra K.M., Chen D.Y., Fearon E.R. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 2002, 62:1613-1618.
58. Vuoriluoto K., Haugen H., Kiviluoto S., Mpindi J.P., Nevo J., Gjerdrum C., Tiron C., Lorens J.B., Ivaska J. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 2011, 30:1436-1448.
59. Navolanic P.M., Steelman L.S., McCubrey J.A. EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review). Int. J. Oncol. 2003, 22:237-252.
60. Kim E.S., Kim M.S., Moon A. Transforming growth factor (TGF)-beta in conjunction with H-ras activation promotes malignant progression of MCF10A breast epithelial cells. Cytokine 2005, 29:84-91.
61. Ma R.Y., Tong T.H., Cheung A.M., Tsang A.C., Leung W.Y., Yao K.M. Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c. J. Cell Sci. 2005, 118:795-806.
62. Xia L.M., Huang W.J., Wang B., Liu M., Zhang Q., Yan W., Zhu Q., Luo M., Zhou Z.Z., Tian D.A. Transcriptional up-regulation of FoxM1 in response to hypoxia is mediated by HIF-1. J. Cell. Biochem. 2009, 106:247-256.
63. Mimeault M., Batra S.K. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells. J. Cell Mol. Med. 2013, 17:30-54.
64. Li J., Wang Y., Luo J., Fu Z., Ying J., Yu Y., Yu W. MiR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells. FEBS Lett. 2012, 586:3761-3765.
65. Benayoun B.A., Caburet S., Veitia R.A. Forkhead transcription factors: key players in health and disease. Trends Genet. 2011, 27:224-232.
66. Mani S.A., Yang J., Brooks M., Schwaninger G., Zhou A., Miura N., Kutok J.L., Hartwell K., Richardson A.L., Weinberg R.A. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc. Natl. Acad. Sci. USA 2007, 104:10069-10074.
67. Nilsson J., Helou K., Kovacs A., Bendahl P.O., Bjursell G., Ferno M., Carlsson P., Kannius-Janson M. Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1. Cancer Res. 2010, 70:2020-2029.
68. Zhang H., Meng F., Liu G., Zhang B., Zhu J., Wu F., Ethier S.P., Miller F., Wu G. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res. 2011, 71:1292-1301.
69. Hennig G., Lowrick O., Birchmeier W., Behrens J. Mechanisms identified in the transcriptional control of epithelial gene expression. J. Biol. Chem. 1996, 271:595-602.
70. Hemavathy K., Guru S.C., Harris J., Chen J.D., Ip Y.T. Human Slug is a repressor that localizes to sites of active transcription. Mol. Cell. Biol. 2000, 20:5087-5095.
71. Bolos V., Peinado H., Perez-Moreno M.A., Fraga M.F., Esteller M., Cano A. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J. Cell Sci. 2003, 116:499-511.
72. Bao B., Wang Z., Ali S., Kong D., Banerjee S., Ahmad A., Li Y., Azmi A.S., Miele L., Sarkar F.H. Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. J. Cell. Biochem. 2011, 112:2296-2306.